Comparing two medications that reduces bp in women developing hypertension after delivery

Comparison of oral amlodipine with oral labetalol in achieving blood pressure control in women with postpartum hypertension. A randomised control study from a tertiary care centre

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063673

Enrollment

200

Registered

2024-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O165- Unspecified maternal hypertension,complicating the puerperium

Interventions

Intervention1: Administration of oral labetalol vs oral amlodipine: Oral amlodipine 2.5 mg OD per oral as long as bp control achieved and oral labetalol 100 mg BD per oral until bp control achieved M

Eligibility

Inclusion criteria

Inclusion criteria: Women with pre eclampsia, eclampsia or De nova postpartum hypertension

Exclusion criteria

Exclusion criteria: Women with absolute contraindications for amlodipine or labetalol , liver dosease disease, renal disease , asthma

Design outcomes

Primary

Measure	Time frame
Comparison of time taken for each drug to control postpartum hypertension Compare the number of doses required to achieve bp control Timepoint: First 6 hours, 72 hours and 6 weeks postpartum	—

Secondary

Measure	Time frame
Reduction in number of doses required by the patient during the hospital stayTimepoint: 72hrs	—

Countries

India

Contacts

Public ContactSajeetha kumari

Srm institute of medical and technical sciences

sajeethaprabhakar@gmail.com9940170195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026